Cross-fund · 4 holders
PTGX
PROTAGONIST THERAPEUTICS INC
CUSIP 74366E102
4
Tracked holders
$1.67B
Aggregate value
16,802,735
Shares
5
Active funds
Funds holding PTGX
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $1.03B | 0.02% | +63,370 | +0.7% |
| Vanguard | Institutional | Q4 2025 | $472.8M | 0.01% | +1,156,461 | +27.2% |
| Citadel | Multi-Strategy | Q1 2026 | $169.1M | 0.03% | +382,513 | +31.3% |
| BridgewaterFEAT | Macro | Q1 2026 | $556,090 | — | +5,276 | NEW |
| Millennium | Multi-Strategy | Q1 2026 | — | — | -17,391 | EXITED |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.